CME

CME


Advocating for Action in HCC: Delivering Impartial and Personalized Care

March 30, 2021

Guest: Monica L. Baskin, PhD

Guest: Josep M. Llovet, MD, PhD

Hepatocellular carcinoma (HCC) is the most common form of liver cancer. Patients with advanced disease at diagnosis typically are not candidates for potentially curative treatment options